RELX PLC (RELX) Fair Value & Analysis
Industrials · US · Market cap $54.9B
RELX PLC
RELX · US
Fair value as of: Aug 13, 2026
From 24 valuation models · updated today
Fair value updated Aug 13, 2026, revised from $32.49 to $32.24 (−0.8%) since Jul 21, 2026. Share price +6.2% over the past month.
A strong business, currently priced close to our fair value.
What matters now
- The price sits close to our fair value, market and models broadly agree here, little valuation tension.
- A fairly wide model range ($19.94 to $41.65) leaves room in how you read the outcome.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Aug 13, 2026.
How to read this chart
60‑month range $21.90 – $54.30 · fair‑value band $19.94 – $41.65 · the $34.67 price screens above the $32.24 fair value. Dashed = 300-day average. As of Aug 13, 2026.
Analysis
RELX PLC (RELX) currently trades at $34.67, while our model-based Fair Value estimate is $32.24, implying the stock looks roughly 7.0% fairly valued today. The Quality Score stands at 83/100 (high quality), in the Industrials sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: high).
Over the trailing twelve months, RELX PLC generated revenue of $9.6B at a net margin of 21.5%. Revenue grew 1.2% year over year. It earns a return on equity of 70.5%. Net debt stands at $7.2B. Fundamentals as of Aug 13, 2026
Our scenario range runs from $19.94 (bear case) to $41.65 (bull case); at $34.67, the current price sits within that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 35% below its 52-week high and 28% above its 52-week low, currently below its 200-day average. For context, the median of 10 Industrials peers we cover trades at -38% fair-value upside, at -7%, RELX screens cheaper than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 24 models by family
Widest divergence: DCF Models ($22.89) versus Asset-Based ($0.9000). Highest evidence: Growth DCF (80).
Notify me when RELX reaches fair value
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Aug 13, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 75 · Market factors (momentum, volatility) 48
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
RELX PLC, together with its subsidiaries, provides information-based analytics and decision tools for professional and business customers in North America, Europe, and internationally. It operates through four segments: Risk; Scientific, Technical & Medical; Legal; and Exhibitions.
Full company description
RELX PLC, together with its subsidiaries, provides information-based analytics and decision tools for professional and business customers in North America, Europe, and internationally. It operates through four segments: Risk; Scientific, Technical & Medical; Legal; and Exhibitions. The Risk segment offers information-based analytics and decision tools that combine public and industry specific content with technology and algorithms to assist clients in evaluating and predicting risk, as well as a portfolio of commercial healthcare products. Its Scientific, Technical & Medical segment provides scientific and medical information and data sets for science and healthcare. The Legal segment provides legal, regulatory, and business information and analytics. Its Exhibitions segment combines digital tools and data to help customers connect in-person and online, discover new markets, source products, generate leads, and transact. The company was formerly known as Reed Elsevier PLC and changed its name to RELX PLC in July 2015. RELX PLC was incorporated in 1903 and is headquartered in London, the United Kingdom.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
RELX PLC reported revenue of $9.6B in FY2025 versus $7.2B in FY2021, a compound +7.3%/yr. Reported net income was $2.1B in FY2025, compounding +8.8%/yr from FY2021.
of which total revenue +4.7 pp · buybacks/dilution +1.5 pp
Absolute contributions in percentage points per year; they sum to the EPS growth rate. Start and end points are 3-year averages (details on hover).
Watch RELX: get an alert when its fair value changes →
Earlier news
External third-party headlines (Yahoo Finance, Reuters and others), not an editorial selection.
Peer Group
Specialty Business Services · 250 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Specialty Business Services median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Specialty Business Services stocks, each showing price versus our Fair Value estimate (as of Aug 13, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Cintas Corporation CTAS | $205.28 | $95.19 | -54% |
| Thomson Reuters Corporation TRI | C$142.85 | C$70.40 | -51% |
| Copart, Inc CPRT | $28.99 | $28.59 | -1% |
| Global Payments Inc GPN | $88.53 | $68.98 | -22% |
| RB Global, Inc RBA | C$120.52 | C$49.14 | -59% |
| Brambles Limited BXB | A$19.89 | A$12.28 | -38% |
| UL Solutions Inc ULS | $76.68 | $33.62 | -56% |
| Aramark ARMK | $60.35 | $13.18 | -78% |
| ISS A/S ISS | kr 288.20 | kr 251.13 | -13% |
| Xiamen C&D Inc 600153 | ¥8.94 | ¥6.84 | -23% |
Compare RELX PLC with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Industrials stocks →
Frequently asked questions
Is RELX PLC (RELX) overvalued or undervalued?
What is the fair value of RELX?
What is the quality score of RELX?
What is the revenue of RELX PLC (RELX)?
What is the net profit margin of RELX?
Does RELX PLC pay a dividend?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track RELX PLC and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.